Ye T, Yan J, Kan T, Xie G, Zhang Z, Yin W
BMC Musculoskelet Disord. 2025; 26(1):165.
PMID: 39966795
PMC: 11837434.
DOI: 10.1186/s12891-025-08419-z.
Buss D, Deering J, Reznikov N, McKee M
JBMR Plus. 2025; 9(2):ziae176.
PMID: 39896117
PMC: 11783288.
DOI: 10.1093/jbmrpl/ziae176.
Sheng M, Rundle C, Baylink D, Lau K
Calcif Tissue Int. 2025; 116(1):28.
PMID: 39789342
PMC: 11717885.
DOI: 10.1007/s00223-024-01337-7.
Xu N, Yang K, Wang M
Cell Biosci. 2024; 14(1):155.
PMID: 39734229
PMC: 11684062.
DOI: 10.1186/s13578-024-01344-z.
Gak N, Abbara A, Dhillo W, Keen R, Comninos A
Front Endocrinol (Lausanne). 2024; 15:1494965.
PMID: 39703866
PMC: 11655223.
DOI: 10.3389/fendo.2024.1494965.
The uremic toxin indoxyl sulfate decreases osteocyte RANKL/OPG and increases Wnt inhibitor RNA expression that is reversed by PTH.
Chen N, ONeill K, Wilson H, Srinivasan S, Bonewald L, Moe S
JBMR Plus. 2024; 9(1):ziae136.
PMID: 39664935
PMC: 11631378.
DOI: 10.1093/jbmrpl/ziae136.
Altered post-fracture systemic bone loss in a mouse model of osteocyte dysfunction.
Osipov B, Emami A, Cunningham H, Orr S, Lin Y, Jbeily E
JBMR Plus. 2024; 8(12):ziae135.
PMID: 39605879
PMC: 11601886.
DOI: 10.1093/jbmrpl/ziae135.
Beyond resorption: osteoclasts as drivers of bone formation.
Xiang Q, Li L, Ji W, Gawlitta D, Walboomers X, van den Beucken J
Cell Regen. 2024; 13(1):22.
PMID: 39392536
PMC: 11469995.
DOI: 10.1186/s13619-024-00205-x.
Characterization of human trabecular bone across multiple length scales using a correlative approach combining X-ray tomography with LaserFIB and plasma FIB-SEM.
Tang T, Casagrande T, Mohammadpour P, Landis W, Lievers B, Grandfield K
Sci Rep. 2024; 14(1):21604.
PMID: 39285214
PMC: 11405866.
DOI: 10.1038/s41598-024-72739-8.
Evidence for peri-lacunar remodeling and altered osteocyte lacuno-canalicular network in mouse models of myeloma-induced bone disease.
Evans H, Andrews R, Abedi F, Sprules A, Trend J, Lovric G
JBMR Plus. 2024; 8(9):ziae093.
PMID: 39108360
PMC: 11299509.
DOI: 10.1093/jbmrpl/ziae093.
Biopsies from patients with sacral insufficiency fracture are characterized by low bone matrix mineralization and high turnover.
Delsmann M, Leonhardt L, Alimy A, Hoenig T, Beil F, Puschel K
JBMR Plus. 2024; 8(9):ziae094.
PMID: 39108359
PMC: 11299542.
DOI: 10.1093/jbmrpl/ziae094.
The osteocytic actions of glucocorticoids on bone mass, mechanical properties, or perilacunar remodeling outcomes are not rescued by PTH(1-34).
Yee C, Meliadis C, Kaya S, Chang W, Alliston T
Front Endocrinol (Lausanne). 2024; 15:1342938.
PMID: 39092287
PMC: 11291448.
DOI: 10.3389/fendo.2024.1342938.
NFATc1 Is Required for Vitamin D- and Phosphate-Mediated Regulation of Osteocyte Lacuno-Canalicular Remodeling.
Jagga S, Hughes A, Manoochehri Arash N, Sorsby M, Brooks D, Divieti Pajevic P
Endocrinology. 2024; 165(8).
PMID: 39024412
PMC: 11492278.
DOI: 10.1210/endocr/bqae087.
PTH receptor signalling, osteocytes and bone disease induced by diabetes mellitus.
Marino S, Bellido T
Nat Rev Endocrinol. 2024; 20(11):661-672.
PMID: 39020007
DOI: 10.1038/s41574-024-01014-7.
A maternal brain hormone that builds bone.
Babey M, Krause W, Chen K, Herber C, Torok Z, Nikkanen J
Nature. 2024; 632(8024):357-365.
PMID: 38987585
PMC: 11306098.
DOI: 10.1038/s41586-024-07634-3.
Connexin hemichannels drive lactation-induced osteocyte acidification and perilacunar-canalicular remodeling.
Hua R, Truong V, Fajardo R, Guda T, Gu S, Jiang J
Cell Rep. 2024; 43(7):114363.
PMID: 38935505
PMC: 11318086.
DOI: 10.1016/j.celrep.2024.114363.
Spatial control of perilacunar canalicular remodeling during lactation.
Sieverts M, Yee C, Nemani M, Parkinson D, Alliston T, Acevedo C
Sci Rep. 2024; 14(1):14655.
PMID: 38918485
PMC: 11199490.
DOI: 10.1038/s41598-024-63645-0.
Aging decreases osteocyte peri-lacunar-canalicular system turnover in female C57BL/6JN mice.
Vahidi G, Boone C, Hoffman F, Heveran C
Bone. 2024; 186:117163.
PMID: 38857854
PMC: 11227388.
DOI: 10.1016/j.bone.2024.117163.
Spatial variations in the osteocyte lacuno-canalicular network density and analysis of the connectomic parameters.
Chen J, Aido M, Roschger A, van Tol A, Checa S, Willie B
PLoS One. 2024; 19(5):e0303515.
PMID: 38743675
PMC: 11093372.
DOI: 10.1371/journal.pone.0303515.
Deletion of FNDC5/irisin modifies murine osteocyte function in a sex-specific manner.
Shimonty A, Pin F, Prideaux M, Peng G, Huot J, Kim H
Elife. 2024; 12.
PMID: 38661340
PMC: 11045224.
DOI: 10.7554/eLife.92263.